Sharps Technology Inc (STSS) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Sharps Technology Inc   (NASDAQ: STSS)

Sharps Technology Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Sharps Technology Inc in the second quarter 2026?
Sharps Technology Inc recorded a cumulative net loss of $-398 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -153.83%.

Within the Medical Equipment & Supplies industry 148 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3116 to 3623.

What is ROE?




Return On Equity (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Equity Change 981.73 % 1663.96 % 13144.64 % 6558.99 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -398 -371 -283 -104 -1
Return On Equity (TTM) -153.83 % -166.42 % -156.45 % -90.62 % -6.49 %
STSS's Total Ranking # 3623 # 3116 # 3278 # 468 # 2306
Equity (TTM) in Millions 157 179 264 433 15
Seq. Equity Change -12.03 % -32.38 % -38.97 % 2879.53 % 43.46 %
Seq. Net Income Change - - - - 84.53 %

Return On Equity Company Ranking
Within: No.
Industry # 149
Sector # 633
Overall # 3623

Return On Equity Statistics
High Average Low
84.82 %
-39.45 %
-166.42 %
(Mar 31 2024)   (Mar 31 2026)



  News about Sharps Technology Inc Return on Equity ROE

Sharps Technologys Future at a Crossroads: CEO Lays Out Ambitious Expansion Plans Amidst Declining ROE and Strategic Stock Split

Revisiting Sharps Technology’s Strategic Path Amidst Manufacturing Expansion and Financial ChallengesBy December 5, 2024 – New York, NYIn a recent shareholder letter, Robert Hayes, the CEO of Sharps Technology, Inc. (NASDAQ: STSS), outlined bold plans for the company s expansion in Hungary, targeting enhanced production capabilities for its SecureGard and SoloGard products. This expansion comes at a critical juncture for the medical device and pharmaceutical packaging company, as it faces notable financial pressures, marked by a decline in return on equity (ROE) and a strategic maneuver involving a reverse stock split.The narrative set forth in Hayes’ letter focuses on bolstering product supply and driving revenue through the new manufacturing facility in Hungary—a location touted for its innovation and efficiency. This expansion is seen as a pivotal move not only to boost production capabilities but also to position Sharps Technology as a formidable player in the European market.




STSS Annual Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022

Total Equity in Millions 264 2 8 10 0
Y / Y Equity Change 13144.64 % -74.84 % -17.7 % - -
Net Income in Millions -283 -9 -10 -5 0
Y / Y Net Income Change - - - - -
Return On Equity -106.85 % -465.71 % -124.04 % -48.12 % -





More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
STSS's' Return on Equity at Yahoo Finance
STSS's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for STSS's Competitors
Subscribers only: Roe for Sharps Technology Inc 's Suppliers
Subscribers only: Return On Equity for STSS's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE


Date modified: 2026-08-14T21:18:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.